Works matching IS 10538569 AND DT 2023 AND VI 32 AND IP 12
Results: 17
Correction to "Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain".
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1446, doi. 10.1002/pds.5712
- Publication type:
- Article
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1319, doi. 10.1002/pds.5691
- By:
- Publication type:
- Article
Identification of risk factors for adverse drug reactions in a pharmacovigilance database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1431, doi. 10.1002/pds.5679
- By:
- Publication type:
- Article
Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1406, doi. 10.1002/pds.5676
- By:
- Publication type:
- Article
Validation of ICD‐10 hospital discharge diagnosis codes to identify incident and recurrent ischemic stroke from a US integrated healthcare system.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1439, doi. 10.1002/pds.5675
- By:
- Publication type:
- Article
Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1411, doi. 10.1002/pds.5674
- By:
- Publication type:
- Article
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1395, doi. 10.1002/pds.5672
- By:
- Publication type:
- Article
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1350, doi. 10.1002/pds.5665
- By:
- Publication type:
- Article
Risk of cancer with immunosuppressants compared to immunomodulators in multiple sclerosis: A nested case–control study within the French nationwide claims database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1421, doi. 10.1002/pds.5669
- By:
- Publication type:
- Article
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1378, doi. 10.1002/pds.5668
- By:
- Publication type:
- Article
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1368, doi. 10.1002/pds.5667
- By:
- Publication type:
- Article
External validity in distributed data networks.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1360, doi. 10.1002/pds.5666
- By:
- Publication type:
- Article
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1387, doi. 10.1002/pds.5671
- By:
- Publication type:
- Article
Decision and timing of safety‐related labeling changes for new drugs in Japan: Comparison with the United States and the European Union.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1331, doi. 10.1002/pds.5664
- By:
- Publication type:
- Article
Investigation of hepatic adverse events due to quetiapine by using the common data model.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1341, doi. 10.1002/pds.5663
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1448, doi. 10.1002/pds.5476
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1, doi. 10.1002/pds.5475
- Publication type:
- Article